PDCD1 and hepatocellular carcinoma: For example, studies based on MRI and contrast-enhanced CT showed that radiomic models have demonstrated precise prediction capabilities for responses to TKI, TKI plus anti-PD-1 antibody, and anti-PD-1 antibodies for advanced HCC patients (33–35), thus preliminarily supporting its favorable predictive performance.